HDAC5 and Hypertension: Although the detailed mechanism of LMK235 in the regulation of vasoconstriction remains elusive, pharmacological inhibition of class I HDACs or knockdown of HDAC5 could be a novel therapeutic strategy for the treatment of hypertension.